ICMR Unveils Indigenous Dual-Stage Malaria Vaccine

ICMR is developing AdFalciVax, India’s first indigenous recombinant chimeric malaria vaccine, targeting two key stages of Plasmodium falciparum. Promising broader protection and extended shelf life, the vaccine aims to curb both infection and transmission. Still in early stages, AdFalciVax aligns with the ‘Make in India’ vision for global malaria.